Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2007
04/17/2007US7205135 Regulation of human adenylate cyclase
04/17/2007US7205134 Δ4-desaturase genes and uses thereof
04/17/2007US7205131 Process for the preparation of L-amino acids via overexpression of the PTSH gene
04/17/2007US7205130 Bi-directionally cloned random cDNA expression vector libraries, compositions and methods of use
04/17/2007US7205129 Method for reducing artifacts in nucleic acid amplification
04/17/2007US7205128 Method for synthesis of the second strand of cDNA
04/17/2007US7205127 Methods of treating insulin resistance with an inhibitor of an NAD(P)H oxidase
04/17/2007US7205126 Made by disrupting HPV-virus-like particles including a chelating agent, mixing them with plasmids and reassembling them into the pseudoviruses (VLPs with plasmids inside) adding a stop buffer to reassemble the VLPs into pseudoviruses; administering to the mucosa; can be applied in gene therapy
04/17/2007US7205124 Utrophin gene promoter
04/17/2007US7205123 Recombinant materials for carotenoid production
04/17/2007US7205120 Detection Alzheimer's disease
04/17/2007US7205109 Method for detecting hepatocarcinoma susceptibility by detecting a tumor related gene in the region of human chromosome 17 p. 13. 3
04/17/2007US7205108 Trp8, Trp9 and Trp10, novel markers for cancer
04/17/2007US7205107 CATT-tetranucleotide repeat polymorphism at position-817 of the human Mif gene that functionally affects the activity of the Macrophage Inhibitory Factor (MIF) promoter in gene reporter assays
04/17/2007US7205104 Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
04/17/2007US7205103 Method of regulating transcription in a cell
04/17/2007US7205101 Replicating DNA specific for HIV by growing a unicellular microorganism containing a DNA construct having an origin of replication recognized by the microorganism and sequence comprising at least a 20 bp sequence of a human immunodeficiency virus genome
04/17/2007US7205013 Infectious Respiratory Syncytial Viral particle for use as gene transfer tool in genetic engineering
04/17/2007US7204991 Porphyromonas gingivalis recombinant proteins and truncations
04/17/2007US7204989 For diagnosis of Hepatitis E virus, use in a vaccine for the prevention of HEV in humans
04/17/2007US7204984 Acetyllysine-recognizing monoclonal antibody and process for producing the same
04/17/2007CA2386539C Method for production of l-cysteine or l-cysteine derivatives by fermentation
04/17/2007CA2310510C Method for identifying and inhibiting functional nucleic acid molecules in cells
04/17/2007CA2287902C Isolated nucleic acid molecules encoding ssx family members and uses thereof
04/17/2007CA2264495C A lactic acid bacterial regulatable expression system
04/17/2007CA2231332C Bacterial delivery system
04/17/2007CA2202477C Method, reagent and kit for evaluating susceptibility to premature atherosclerosis and treatment of same using gene therapy
04/17/2007CA2199213C Amplifying and detecting target nucleic acids using a post amplification incubation step
04/17/2007CA2196876C Trefoil peptide dimer
04/17/2007CA2184175C Isolated, tyrosinase derived peptides and uses thereof
04/17/2007CA2175478C Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease
04/17/2007CA2174648C Apparatus and method for polymer synthesis using arrays
04/17/2007CA2171759C Methods and compositions for high protein production from recombinant dna
04/17/2007CA2169854C Enhanced expression in plants using non-translated leader sequences
04/17/2007CA2166118C Adenovirus vectors for gene therapy
04/17/2007CA2149326C Fully impaired consensus kozak sequences for mammalian expression
04/17/2007CA2148578C Humanized antibodies to fc receptors for immunoglobulin g on human mononuclear phagocytes
04/17/2007CA2141212C Defective adenovirus and corresponding complementation lines
04/17/2007CA2133205C Stable polypeptide composition
04/17/2007CA2127450C Transgenic animal models for alzheimer's disease
04/17/2007CA2106819C Oligoribonucleotide and ribozyme analogs with terminal 3'-3' and/or 5'-5' linkages
04/17/2007CA2100690C Megakaryocyte differentiation factor
04/17/2007CA2073298C Process for controlling contamination of nucleic acid amplification reactions
04/17/2007CA1341525C Biologically active bactericidal/permeability-increasing protein fragments
04/14/2007CA2564064A1 Genetic variations associated with psychiatric disorders
04/14/2007CA2523399A1 Genetic variations associated with psychiatric disorders
04/13/2007CA2564464A1 Multiplexed solid-phase nucleic acid amplification assay
04/12/2007WO2007041687A1 Rat trpm7 polynucleotide and encoded protein
04/12/2007WO2007041439A2 Centrosomal proteins, nucleic acids and method of use thereof
04/12/2007WO2007041438A2 Compositions comprising glycerophosphodiester phosphodiesterase (gde) and uses thereof
04/12/2007WO2007041419A1 Transgenic plant seed with increased lysine
04/12/2007WO2007041251A2 System for detecting protein-protein interactions
04/12/2007WO2007041218A2 Regulation of tool-like receptors on stem cells
04/12/2007WO2007041213A2 Methods for regulation of p53 translation and function
04/12/2007WO2007040546A2 Production of recombinant protein pap 31 for the diagnosis and prevention of bartonella bacilliformis infection
04/12/2007WO2007040541A1 Re-engineered uv damage endonuclease, compositions and methods
04/12/2007WO2007040437A1 Fusion proteins having a modulated half-life in plasma
04/12/2007WO2007040219A1 Nanoarray dna chip
04/12/2007WO2007040162A1 Process for producing recombinant human thrombin by cultured cell
04/12/2007WO2007040123A1 Method for detection of human precursor t cell and precursor b cell
04/12/2007WO2007040105A1 Method for production of t cell population
04/12/2007WO2007039986A1 Method of obtaining pancreatic endocrine cells from adipose tissue-origin cells
04/12/2007WO2007039963A1 Brain tumor marker for prediction of prognosis of patient with brain tumor and use thereof
04/12/2007WO2007039920A1 A method for the transfer of episomal vectors into animal cells
04/12/2007WO2007039788A1 Composition and methods for inhibiting h. pylori adhesion and infection
04/12/2007WO2007039714A1 Expression control using antibody expression optimisation sequences
04/12/2007WO2007039699A2 Proteinaceous substrate for the detection of calpain-3 activity
04/12/2007WO2007039645A1 African trypanosomiasis therapy with a nanobody-conjugated human trypanolytic factor
04/12/2007WO2007039632A1 Novel selection system
04/12/2007WO2007039507A2 Methods of identifying antibodies to ligands of orphan receptors
04/12/2007WO2007039465A2 Tetrahymena bifunctional dihydrofolate reductase - thymidylate synthase deficiency and its use
04/12/2007WO2007039461A1 In vivo generation of dna, rna, peptide, and protein libraries
04/12/2007WO2007039454A1 Methods for controlling gene expression using ta-siran
04/12/2007WO2007039442A2 Nucleic acid molecules encoding constitutive triple response1-like polypeptides and methods of use thereof
04/12/2007WO2007039424A1 D-amino acid a selectable marker for barley (hordeum vulgare l.) transformation
04/12/2007WO2007039317A2 Plants having an increased content of amino sugars
04/12/2007WO2007039316A1 Improved methods and means for producings hyaluronan
04/12/2007WO2007039315A1 Plants with an increased production of hyaluronan ii
04/12/2007WO2007039314A2 Plants with increased hyaluronan production
04/12/2007WO2007039258A1 Use of a cellular extract for a mitotic remodeling of chromosomes
04/12/2007WO2007039255A1 Tumor angiogenesis associated genes and a method for their identification
04/12/2007WO2007039182A1 oriC SPECIFIC NUCLEIC ACID SEQUENCES AND USE THEREOF
04/12/2007WO2007039137A1 Red lettuce
04/12/2007WO2007039109A1 Tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi) -anchors for treatment of cancer and skin lesions
04/12/2007WO2007039070A2 Polynucleotides of haemophilus parasuis and its use
04/12/2007WO2007038876A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
04/12/2007WO2007038869A1 Aptamers comprising arabinose modified nucleotides
04/12/2007WO2007038862A1 Nucleic acid immunological composition for human metapneumovirus
04/12/2007WO2007038837A1 Silk proteins
04/12/2007WO2007022623B1 Regulation of heterologous recombinant protein expression in methylotrophic and methanotrophic bacteria
04/12/2007WO2007014744A3 C-terminal tnf-family ligand (ctl) -prodrug
04/12/2007WO2007012605A3 Static support bed for purification, separation, detection, modification and/or immobilization of target entities and method using thereof
04/12/2007WO2007012377A3 Methods for the electromanipulation of cells in order to modify the membrane permeability of said cells with the aid of lipophilic ions as a medium additive
04/12/2007WO2007010080A3 Novel carbosilane dendrimers, preparation method thereof and use of same
04/12/2007WO2007005781A3 Dna vector production system
04/12/2007WO2007004172A8 Production of recombinant products using capillary membranes
04/12/2007WO2007003421A3 Humanised antibodies specific for nogo-a and pharmaceutical uses thereof
04/12/2007WO2006134523A3 Novel sesquiterpene synthases and methods of their use
04/12/2007WO2006133911A3 Hepatitis c virus nucleic acid vaccine
04/12/2007WO2006133441A3 Method of increasing fibre yield in cotton